The similarities among the Houses of procedure streams in biologic-drug output and product streams in other industries—like the food stuff and beverage, industrial enzyme, plasma fractionation, and wastewater-processing industries—present possibilities for that adoption of other device operations. Harvest operations for biologics have extended